Shalby (NSE:SHALBY) 3-Year RORE % : -52.08% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SHALBY Shalby Ltd NSE:SHALBY
92 GF Score
Price ₹165.92
GF Value ₹251.67
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Shalby 3-Year RORE %?

Shalby NSE:SHALBY +0.63% 92 3-Year RORE % is -52.08 as of Mar. 2026. GuruFocus rates NSE:SHALBY with a GF Score™ of 92/100 and a GF Value™ of ₹251.67 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 602 Healthcare Providers & Services companies, Shalby ranks worse than 82.39% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Shalby's 3-Year RORE % for the quarter that ended in Mar. 2026 was -52.08%.

The industry rank for Shalby's 3-Year RORE % or its related term are showing as below:

NSE:SHALBY's 3-Year RORE % is ranked worse than
82.39% of 602 companies
in the Healthcare Providers & Services industry
Industry Median: 0.195 vs NSE:SHALBY: -52.08

Shalby  (NSE:SHALBY) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Shalby 3-Year RORE % Related Terms


Shalby 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Shalby's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shalby 3-Year RORE % Chart

Shalby Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 64.27 23.51 17.86 -55.88 -52.08

Shalby Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -55.88 -70.10 -74.46 -85.52 -52.08

NSE:SHALBY vs HCA, THC, DVA: 3-Year RORE % Comparison

For the Medical Care Facilities subindustry, Shalby's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shalby 3-Year RORE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Shalby's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Shalby's 3-Year RORE % falls into.


NSE:SHALBY
92GF Score
Shalby Ltd NSE:SHALBY
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shalby 3-Year RORE % Calculation

Shalby's 3-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( 3.23-7.839 )/( 11.249-2.4 )
=-4.609/8.849
=-52.08 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of -52.08 mean?
Shalby (NSE:SHALBY) has a 3-Year RORE % of -52.08 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Shalby and its competitors. According to the industry distribution chart, Shalby ranks #496 out of 602 companies in the Healthcare Providers & Services industry, placing it in the top 82.4%.
Is Shalby's 3-Year RORE % too high?
Shalby's current 3-Year RORE % is -52.08. Based on the distribution chart, Shalby ranks #496 out of 602 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Shalby has a GF Score™ of 92/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shalby's 3-Year RORE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Shalby ranks #496 out of 602 companies for 3-Year RORE %. This places Shalby in the lower half of its industry. The industry median 3-Year RORE % is 0.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
The median 3-Year RORE % among Healthcare Providers & Services companies is 0.20, based on 602 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Shalby and its competitors. For the Healthcare Providers & Services industry, the median 3-Year RORE % is 0.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shalby's current 3-Year RORE % is -52.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shalby stock overvalued right now?
Based on GuruFocus' analysis, Shalby (NSE:SHALBY) is currently considered Possible Value Trap. The stock's GF Value™ is ₹251.67, compared to a current price of ₹165.92 — trading 34.1% below its estimated fair value. The current 3-Year RORE % is -52.08. Shalby's overall GF Score™ is 92/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Shalby (NSE:SHALBY), the current 3-Year RORE % is -52.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shalby (NSE:SHALBY) Overvalued in 2026?

Based on GuruFocus' analysis, Shalby stock appears to be undervalued. The current stock price of ₹165.92 is trading 34.1% below its estimated GF Value™ of ₹251.67. GuruFocus considers Shalby to be Possible Value Trap.

Key valuation signals for NSE:SHALBY:

  • 3-Year RORE %: -52.08
  • GF Value™: ₹251.67 vs. price of ₹165.92 (34.1% below fair value)
  • GF Score™: 92/100 with 5 warning signs

No single metric tells the full story. See the NSE:SHALBY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shalby Business Description

Other Exchanges 540797:India
Address Opposite Karnavati Club, S. G. Highway, B-301 & 302, Mondeal Heights, Ahmedabad, GJ, IND, 380 015
Shalby Ltd operates a chain of multispecialty hospitals. It is engaged in setting up and managing hospitals and medical diagnostic services. The hospitals offer healthcare services to patients in various areas of specialization such as Cardiology, Emergency Medicine, Gastroenterology Surgery, Arthroscopy Sports Injury, Infectious Diseases, Oncology, and others. The activities are mainly conducted only in India. Revenue mainly comprises fees charged for inpatient and outpatient hospital services. Services include charges for accommodation, medical professional services, equipment, radiology, laboratory, and pharmaceutical goods used in treatments given to Patients.
92GF Score

Get the complete analysis for NSE:SHALBY

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹165.92
Price
₹251.67
GF Value